Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...

Headlamp Health today announced the launch of Lumos AI®, a comprehensive decision-support platform designed to help drug developers address the complexity that has long stalled neuroscience progress.

IN a bid to spark curiosity and inspire young minds, senior high school students from Rajah Soliman Science and Technology ...

Earable® Neuroscience, creator of the three-time CES Innovation Award-winning FRENZ Brainband, today announced two major ...

A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases - ...

Today, on the opening day at CES, Neurable announced it’s working with HP Inc.’s HyperX gaming brand to develop an ...

AI VTuber Neuro-Sama has shattered Twitch records, reaching Hype Train Level 126 and gaining over 262,000 subscribers during ...

BrainsWay’s SWIFT depression protocol consists of an acute phase of five treatment sessions (ten minutes each) per day for ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people are already affected worldwide, and the number is continually climbing. Men ...

KeifeRx, announced that Chief Executive Officer Chris Hoyt will be speaking at two leading investor events during J.P. Morgan Healthcare Conference week. WASHINGTON, DC, UNITED STATES, January 5, 2026 ...

Nike's Mind footwear collection uses 22 foam nodes per shoe to stimulate neural pathways through feet, targeting brain focus ...

A model predicting the point at which AI could develop a ‘superintelligence’ and develop autonomously has been delayed ...